Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Brimonidine Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Oral
  • 1.4.3 Eye Drops
• 1.5 Market by Application
  • 1.5.1 Global Brimonidine Market Share by Application (2014-2025)
  • 1.5.2 Open-angle Glaucoma
  • 1.5.3 High Intraocular Pressure
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Brimonidine Market Size
• 2.2 Brimonidine Growth Trends by Regions
  • 2.2.1 Brimonidine Market Size by Regions (2014-2025)
  • 2.2.2 Brimonidine Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Brimonidine Market Size by by Players
  • 3.1.1 Global Brimonidine Revenue by by Players (2014-2019)
  • 3.1.2 Global Brimonidine Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Brimonidine Market Concentration Ratio (CR5 and HHI)
• 3.2 Brimonidine Key Players Head office and Area Served
• 3.3 Key Players Brimonidine Product/Solution/Service
• 3.4 Date of Enter into Brimonidine Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Brimonidine Market Size by Type (2014-2019)
• 4.2 Global Brimonidine Market Size by Application (2014-2019)

5 United States

• 5.1 United States Brimonidine Market Size (2014-2019)
• 5.2 Brimonidine Key Players in United States
• 5.3 United States Brimonidine Market Size by Type
• 5.4 United States Brimonidine Market Size by Application

6 Europe

• 6.1 Europe Brimonidine Market Size (2014-2019)
• 6.2 Brimonidine Key Players in Europe
• 6.3 Europe Brimonidine Market Size by Type
• 6.4 Europe Brimonidine Market Size by Application

7 China

• 7.1 China Brimonidine Market Size (2014-2019)
• 7.2 Brimonidine Key Players in China
• 7.3 China Brimonidine Market Size by Type
• 7.4 China Brimonidine Market Size by Application

8 Japan

• 8.1 Japan Brimonidine Market Size (2014-2019)
• 8.2 Brimonidine Key Players in Japan
• 8.3 Japan Brimonidine Market Size by Type
• 8.4 Japan Brimonidine Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Brimonidine Market Size (2014-2019)
• 9.2 Brimonidine Key Players in Southeast Asia
• 9.3 Southeast Asia Brimonidine Market Size by Type
• 9.4 Southeast Asia Brimonidine Market Size by Application

10 India

• 10.1 India Brimonidine Market Size (2014-2019)
• 10.2 Brimonidine Key Players in India
• 10.3 India Brimonidine Market Size by Type
• 10.4 India Brimonidine Market Size by Application

11 Central & South America

• 11.1 Central & South America Brimonidine Market Size (2014-2019)
• 11.2 Brimonidine Key Players in Central & South America
• 11.3 Central & South America Brimonidine Market Size by Type
• 11.4 Central & South America Brimonidine Market Size by Application

12 International Players Profiles

• 12.1 Allergan
  • 12.1.1 Allergan Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Brimonidine Introduction
  • 12.1.4 Allergan Revenue in Brimonidine Business (2014-2019)
  • 12.1.5 Allergan Recent Development
• 12.2 Physicians Total Care
  • 12.2.1 Physicians Total Care Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Brimonidine Introduction
  • 12.2.4 Physicians Total Care Revenue in Brimonidine Business (2014-2019)
  • 12.2.5 Physicians Total Care Recent Development
• 12.3 Pharmascience
  • 12.3.1 Pharmascience Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Brimonidine Introduction
  • 12.3.4 Pharmascience Revenue in Brimonidine Business (2014-2019)
  • 12.3.5 Pharmascience Recent Development
• 12.4 Aa Pharma
  • 12.4.1 Aa Pharma Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Brimonidine Introduction
  • 12.4.4 Aa Pharma Revenue in Brimonidine Business (2014-2019)
  • 12.4.5 Aa Pharma Recent Development
• 12.5 Novartis
  • 12.5.1 Novartis Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Brimonidine Introduction
  • 12.5.4 Novartis Revenue in Brimonidine Business (2014-2019)
  • 12.5.5 Novartis Recent Development
• 12.6 Galderma
  • 12.6.1 Galderma Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Brimonidine Introduction
  • 12.6.4 Galderma Revenue in Brimonidine Business (2014-2019)
  • 12.6.5 Galderma Recent Development
• 12.7 Akorn
  • 12.7.1 Akorn Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Brimonidine Introduction
  • 12.7.4 Akorn Revenue in Brimonidine Business (2014-2019)
  • 12.7.5 Akorn Recent Development
• 12.8 Apotex Corporation
  • 12.8.1 Apotex Corporation Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Brimonidine Introduction
  • 12.8.4 Apotex Corporation Revenue in Brimonidine Business (2014-2019)
  • 12.8.5 Apotex Corporation Recent Development
• 12.9 Pacific Pharma
  • 12.9.1 Pacific Pharma Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Brimonidine Introduction
  • 12.9.4 Pacific Pharma Revenue in Brimonidine Business (2014-2019)
  • 12.9.5 Pacific Pharma Recent Development
• 12.10 Osmotica Pharmaceutical
  • 12.10.1 Osmotica Pharmaceutical Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Brimonidine Introduction
  • 12.10.4 Osmotica Pharmaceutical Revenue in Brimonidine Business (2014-2019)
  • 12.10.5 Osmotica Pharmaceutical Recent Development
• 12.11 Somerset Therapeutics
• 12.12 Teva Pharmaceutical Industries

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

In 2018, the global Brimonidine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Brimonidine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Brimonidine development in United States, Europe and China.

The key players covered in this study
Allergan
Physicians Total Care
Pharmascience 
Aa Pharma
Novartis
Galderma
Akorn
Apotex Corporation
Pacific Pharma
Osmotica Pharmaceutical 
Somerset Therapeutics
Teva Pharmaceutical Industries

Market segment by Type, the product can be split into
Oral
Eye Drops

Market segment by Application, split into
Open-angle Glaucoma
High Intraocular Pressure
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Brimonidine status, future forecast, growth opportunity, key market and key players.
To present the Brimonidine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Brimonidine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.